X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5285) 5285
Publication (456) 456
Book Review (66) 66
Newsletter (65) 65
Newspaper Article (23) 23
Magazine Article (13) 13
Book Chapter (8) 8
Conference Proceeding (7) 7
Dissertation (2) 2
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4236) 4236
antifungal agents - therapeutic use (3572) 3572
itraconazole (2979) 2979
itraconazole - therapeutic use (2726) 2726
male (2519) 2519
female (1968) 1968
adult (1623) 1623
index medicus (1567) 1567
middle aged (1437) 1437
pharmacology & pharmacy (931) 931
treatment outcome (897) 897
aged (822) 822
amphotericin b - therapeutic use (816) 816
animals (794) 794
microbiology (787) 787
infectious diseases (781) 781
fluconazole (711) 711
antifungal agents - administration & dosage (696) 696
voriconazole (627) 627
dermatology (623) 623
antifungal agents - pharmacology (582) 582
aspergillosis - drug therapy (569) 569
adolescent (544) 544
fluconazole - therapeutic use (541) 541
itraconazole - administration & dosage (526) 526
mycology (515) 515
ketoconazole - therapeutic use (509) 509
mycoses - drug therapy (500) 500
amphotericin-b (495) 495
administration, oral (479) 479
mycoses (470) 470
antifungal agents (451) 451
triazoles - therapeutic use (436) 436
microbial sensitivity tests (435) 435
child (427) 427
infections (410) 410
therapy (383) 383
terbinafine (379) 379
immunology (377) 377
aspergillosis (376) 376
drug therapy, combination (375) 375
antifungal agents - adverse effects (369) 369
itraconazole - pharmacology (364) 364
diagnosis (357) 357
onychomycosis - drug therapy (351) 351
ketoconazole - analogs & derivatives (350) 350
infection (345) 345
veterinary sciences (324) 324
dermatomycoses - drug therapy (318) 318
health aspects (310) 310
immunocompromised host (303) 303
naphthalenes - therapeutic use (294) 294
amphotericin b (289) 289
histoplasmosis - drug therapy (289) 289
care and treatment (288) 288
drug interactions (286) 286
fungal infections (285) 285
ketoconazole (275) 275
medicine, general & internal (272) 272
pharmacokinetics (272) 272
diagnosis, differential (270) 270
fungi (269) 269
drug therapy (265) 265
retrospective studies (259) 259
onychomycosis (258) 258
fungal-infections (255) 255
dermatology & venereal diseases (254) 254
posaconazole (245) 245
lung diseases, fungal - drug therapy (244) 244
itraconazole - adverse effects (242) 242
candidiasis - drug therapy (239) 239
invasive aspergillosis (235) 235
epidemiology (231) 231
transplantation (231) 231
follow-up studies (221) 221
aids-related opportunistic infections - drug therapy (219) 219
double-blind (218) 218
risk factors (216) 216
aids (214) 214
mycoses - prevention & control (214) 214
antifungal agents - pharmacokinetics (213) 213
child, preschool (209) 209
pyrimidines - therapeutic use (209) 209
mice (205) 205
in-vitro (203) 203
young adult (201) 201
research (193) 193
histoplasmosis - diagnosis (192) 192
aspergillosis - microbiology (189) 189
mycoses - microbiology (189) 189
aspergillus (185) 185
analysis (179) 179
recurrence (178) 178
efficacy (174) 174
patient (174) 174
aged, 80 and over (173) 173
drug resistance, fungal (172) 172
triazoles - pharmacology (172) 172
oncology (171) 171
susceptibility (170) 170
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4907) 4907
French (121) 121
Spanish (103) 103
German (79) 79
Japanese (58) 58
Chinese (33) 33
Dutch (18) 18
Italian (18) 18
Portuguese (16) 16
Polish (11) 11
Russian (11) 11
Bulgarian (6) 6
Turkish (6) 6
Finnish (4) 4
Romanian (3) 3
Czech (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Microbiology and Infection, ISSN 1198-743X, 05/2018, Volume 24, pp. e1 - e38
The European Society for Clinical Microbiology and Infectious Diseases, the European Confederation of Medical Mycology and the European Respiratory Society... 
Invasive fungal infection | Transplantation | Haematology | Treatment | Diagnosis | Aspergillosis | BRONCHOALVEOLAR LAVAGE FLUID | INFECTIOUS DISEASES | MICROBIOLOGY | BETA-D-GLUCAN | LIPOSOMAL AMPHOTERICIN-B | REAL-TIME PCR | INVASIVE PULMONARY ASPERGILLOSIS | POLYMERASE-CHAIN-REACTION | INTENSIVE-CARE-UNIT | CENTRAL-NERVOUS-SYSTEM | STEM-CELL TRANSPLANTATION | CRITICALLY-ILL PATIENTS | Biopsy - methods | Nitriles - pharmacology | Voriconazole - pharmacology | Humans | Bronchoalveolar Lavage | Aspergillosis - diagnosis | Tomography, X-Ray Computed | Leukemia, Myeloid, Acute - complications | Itraconazole - pharmacology | Mannans - analysis | Antifungal Agents - therapeutic use | Microbial Sensitivity Tests | Myelodysplastic Syndromes - therapy | Aspergillus - isolation & purification | Aspergillosis - complications | Leukemia, Myeloid, Acute - therapy | Aspergillosis - drug therapy | Pyridines - therapeutic use | Triazoles - therapeutic use | Antifungal Agents - pharmacology | Immunologic Tests | Aspergillus - immunology | Voriconazole - therapeutic use | Antibodies, Fungal - blood | Myelodysplastic Syndromes - complications | Invasive Pulmonary Aspergillosis - diagnosis | Aspergillus - drug effects | Itraconazole - therapeutic use | Triazoles - pharmacology | Magnetic Resonance Imaging | Flucytosine - therapeutic use | Disease Management | Pyridines - pharmacology | Flucytosine - pharmacology | Immunocompromised Host | Early Diagnosis | Aspergillosis - immunology | Nitriles - therapeutic use | Life Sciences | Microbiology and Parasitology | Immunology | Bacteriology | Virology
Journal Article
Current Medical Research & Opinion, ISSN 0300-7995, 01/2013, Volume 29, Issue 1, pp. 1 - 12
Abstract Background: Rifampin is a potent inducer of both cytochrome P-450 oxidative enzymes and the P-glycoprotein transport system. Among numerous well... 
Rifabutin | Rifampin | Rifapentine | Drug interactions | MEDICINE, RESEARCH & EXPERIMENTAL | ENZYME-INDUCTION | PLATELET-AGGREGATION | TUBERCULOSIS | OPEN-LABEL | ATORVASTATIN | SINGLE-BLIND | MEDICINE, GENERAL & INTERNAL | PHARMACOKINETICS | PLASMA-CONCENTRATIONS | HEALTHY-VOLUNTEERS | TRANSPORTER INHIBITION | Rifampin - analogs & derivatives | Simvastatin - therapeutic use | Antifungal Agents - adverse effects | Digoxin - adverse effects | Simvastatin - adverse effects | Antibiotics, Antitubercular - adverse effects | Humans | ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism | Antifungal Agents - therapeutic use | Rifampin - adverse effects | Verapamil - therapeutic use | Drug Interactions | Verapamil - adverse effects | Rifampin - therapeutic use | Contraceptives, Oral - adverse effects | Contraceptives, Oral - therapeutic use | Digoxin - therapeutic use | HIV Protease Inhibitors - adverse effects | Rifabutin - adverse effects | Anti-Arrhythmia Agents - therapeutic use | HIV Protease Inhibitors - therapeutic use | Anticholesteremic Agents - adverse effects | Itraconazole - therapeutic use | Anticholesteremic Agents - therapeutic use | Anti-Arrhythmia Agents - adverse effects | Itraconazole - adverse effects | Antibiotics, Antitubercular - therapeutic use | Cytochrome P-450 Enzyme System - biosynthesis | Rifabutin - therapeutic use | ATP Binding Cassette Transporter, Sub-Family B | Index Medicus
Journal Article
Cancer Cell, ISSN 1535-6108, 01/2013, Volume 23, Issue 1, pp. 23 - 34
Journal Article